DSUVIA
Total Payments
$2.5M
Transactions
6,558
Doctors
3,123
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2,627 | 135 | 121 |
| 2023 | $2,756 | 134 | 124 |
| 2022 | $534,430 | 810 | 575 |
| 2021 | $701,748 | 2,152 | 1,179 |
| 2020 | $628,370 | 1,594 | 897 |
| 2019 | $670,511 | 1,733 | 839 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $1.0M | 503 | 40.3% |
| Consulting Fee | $643,455 | 259 | 25.3% |
| Unspecified | $504,663 | 25 | 19.9% |
| Food and Beverage | $232,708 | 5,178 | 9.2% |
| Travel and Lodging | $135,569 | 503 | 5.3% |
| Education | $476.13 | 90 | 0.0% |
Payments by Type
General
$2.0M
6,533 transactions
Research
$504,663
25 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Cardio Thoracic Study | AcelRx Pharmaceuticals, Inc. | $165,506 | 0 |
| ED Sickle Cell Pain Management Study | AcelRx Pharmaceuticals, Inc. | $81,859 | 0 |
| Use of DSUVIA in Patients Undergoing Spine Surgery | AcelRx Pharmaceuticals, Inc. | $80,000 | 0 |
| Orthopedic Education Study | AcelRx Pharmaceuticals, Inc. | $73,480 | 0 |
| Plastic Surgery Education | AcelRx Pharmaceuticals, Inc. | $44,175 | 0 |
| Plastic Surgery Education Study | AcelRx Pharmaceuticals, Inc. | $25,268 | 0 |
| A Pilot Study Assessing the Effects of Sublingual Sufentanil 30 mcg on Postoperative Recovery from Ambulatory Surgery | AcelRx Pharmaceuticals, Inc. | $24,375 | 0 |
| Pilot Study of Postoperative Use of DSUVIA (sufentanil sublingual tablet, 30 mcg) after Total Abdominal Hysterectomy | AcelRx Pharmaceuticals, Inc. | $5,000 | 0 |
| Pilot Study of Postoperative Use of DSUVIA sufentanil sublingual tablet, 30 mcg after Total Abdominal Hysterectomy | AcelRx Pharmaceuticals, Inc. | $5,000 | 0 |
Top Doctors Receiving Payments for DSUVIA — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Anesthesiology | Scottsdale, AZ | $11,963 | 15 |
| , CRNA | Nurse Anesthetist, Certified Registered | St Louis, MO | $11,448 | 12 |
| , M.D | Otolaryngology | San Diego, CA | $10,964 | 13 |
| , MD | Emergency Medicine | Southfield, MI | $10,337 | 17 |
| , M.D | Otolaryngology | Henderson, NV | $7,250 | 5 |
| , MD | Emergency Medicine | Cleveland, OH | $7,216 | 6 |
| , M.D | Physical Medicine & Rehabilitation | Chester, NJ | $6,513 | 10 |
| , MD | Surgical Critical Care | Chicago, IL | $6,101 | 7 |
| , M.D | Colon & Rectal Surgery | Houston, TX | $5,905 | 9 |
| , DO | Internal Medicine | Harrisburg, PA | $5,868 | 5 |
| , MD | Anesthesiology | Los Angeles, CA | $5,535 | 15 |
| , M.D | Emergency Medicine | Mission Viejo, CA | $5,476 | 9 |
| , M.D | Anesthesiology | Boston, MA | $5,000 | 2 |
| , M. D | Specialist | San Antonio, TX | $4,997 | 7 |
| , D.O | Adult Reconstructive Orthopaedic Surgery | Palos Hills, IL | $4,968 | 4 |
| , M.D | Dermatology | Palo Alto, CA | $4,919 | 9 |
| , MD | Anesthesiology | Columbus, OH | $4,729 | 6 |
| , MD | Surgery | Springfield, MO | $4,592 | 3 |
| , MD | Sports Medicine | Norwood, MA | $4,402 | 4 |
| , MD | Orthopaedic Surgery | Bingham Farms, MI | $4,185 | 4 |
| , MD | Anesthesiology | Dallas, TX | $4,140 | 12 |
| , M.D | Pain Medicine | Dallas, TX | $4,139 | 5 |
| , M.D | Specialist | Houston, TX | $4,125 | 17 |
| , MD | Anesthesiology | Fort Worth, TX | $4,124 | 11 |
| , M.D | Surgery | Glendale, AZ | $3,967 | 3 |
Ad
Manufacturing Companies
- AcelRx Pharmaceuticals, Inc. $2.5M
- Vertical Pharmaceuticals, LLC $5,302
- TETRAPHASE PHARMACEUTICALS, INC. $130.35
- Avion Pharmaceuticals $80.27
Product Information
- Type Drug
- Total Payments $2.5M
- Total Doctors 3,123
- Transactions 6,558
About DSUVIA
DSUVIA is a drug associated with $2.5M in payments to 3,123 healthcare providers, recorded across 6,558 transactions in the CMS Open Payments database. The primary manufacturer is AcelRx Pharmaceuticals, Inc..
Payment data is available from 2019 to 2024. In 2024, $2,627 was paid across 135 transactions to 121 doctors.
The most common payment nature for DSUVIA is "Honoraria" ($1.0M, 40.3% of total).
DSUVIA is associated with 9 research studies, including "Cardio Thoracic Study" ($165,506).